Abstract:Abstract Oral squamous cell carcinoma (OSCC) is widely represented as a heterogeneous tumor with more aggressive phenotypes, but the basis for these characteristics remains unknown. In the current study, we show that up-regulation of the Polycomb complex histone methytransferase EZH2 is critical to maintain the malignant phenotypes in OSCC and associated significantly with oral squamous cell carcinoma development in patients with oral leukoplakia (OLP), which represents oral precancerous lesion as well as the worse prognosis of patients with locally advanced OSCC. Patients with OLP (n=76) and OSCC (n=124) from two independent cohort were included in this study. Immunohistochemical analyses on EZH2 in the two cohort revealed that the higher EZH2 levels were strongly associated with dysplasia (P < 0.001) and OSCC development (P < 0.0001) in patients with OLP, as well as worse overall survival (P = 0.001) and disease free survival (P = 0.002) in patients with locally advanced OSCC. Furthermore, upon EZH2 silencing by small interfering RNA (siRNA)-mediated knockdown, the proliferation, anchorage-independent growth and invasion potential of OLP cell line and OSCC cell lines were remarkably suppressed. Available publicly H3K27 modifications based on CpG array and three public microarray datasets (GEO) analyses identified human four-and-half LIM protein 1(FHL1) as a novel candidate target of EZH2 in OSCC. Further depletion of EZH2 by RNA interference (RNAi), the expression of FHL1 was notably restored in OLP and OSCC cell lines. In addition, ablation of FHL1 by RNA interference promoted significantly proliferation and invasion potential of OSCC cells. Together, our findings indicate that aberrantly elevated EZH2 promotes aggressive phenotypes of OLP and OSCC cells and plays a critical role in initiation and progression of OSCC. meanwhile, FHL1 may be a novel target of EZH2 for transcriptional repression in OSCC initiation and progression. ACKNOWLEDGMENTS: This study was supported by the National Natural Science Foundation of China (Grant No. 30973343), Projects of the Shanghai Science and Technology Committee (Grant No. 08JC1414400 and 10XD1402500) and the Shanghai Leading Academic Discipline Project (S30206). Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr 1143. doi:1538-7445.AM2012-1143

Yin Yang 1‐Induced Long Noncoding RNA DUXAP9 Drives the Progression of Oral Squamous Cell Carcinoma by Blocking CDK1‐Mediated EZH2 Degradation (Adv. Sci. 25/2023)

Yin Yang 1‐Induced Long Noncoding RNA DUXAP9 Drives the Progression of Oral Squamous Cell Carcinoma by Blocking CDK1‐Mediated EZH2 Degradation

Abstract 4721: Yin Yang 1-Induced Long Non-Coding RNA DUXAP9 Drives Oral Squamous Cell Carcinoma by Blocking CDK1-mediated EZH2 Degradation

Long non-coding RNA DUXAP9 promotes the proliferation and metastasis of head and neck squamous cell carcinoma

CDK5RAP2 is a Wnt target gene and promotes stemness and progression of oral squamous cell carcinoma

Forkhead Box D1 Promotes EMT and Chemoresistance by Upregulating Lncrna CYTOR in Oral Squamous Cell Carcinoma

LINC00958 Regulated Mir-627-5p/ybx2 Axis to Facilitate Cell Proliferation and Migration in Oral Squamous Cell Carcinoma.

LncRNA DUXAP9‐206 Directly Binds with Cbl‐b to Augment EGFR Signaling and Promotes Non‐small Cell Lung Cancer Progression

Integrative Profiling Analysis Identifies the Oncogenic Long Noncoding RNA DUXAP8 in Oral Cancer

Exosome‐derived Long Non‐coding RNA ADAMTS9‐AS2 Suppresses Progression of Oral Submucous Fibrosis Via AKT Signalling Pathway

N6-Methyladenosine Modification of LncRNA DUXAP9 Promotes Renal Cancer Cells Proliferation and Motility by Activating the PI3K/AKT Signaling Pathway

LncRNA SNHG20 Enhances the Progression of Oral Squamous Cell Carcinoma by Regulating the Mir-29A/dixdc1/wnt Regulatory Axis.

DEAD/H-box Helicase 11 is Transcriptionally Activated by Yin Yang-1 and Accelerates Oral Squamous Cell Carcinoma Progression.

Dysregulation of FOXD2-AS1 Promotes Cell Proliferation and Migration and Predicts Poor Prognosis in Oral Squamous Cell Carcinoma: a Study Based on TCGA Data.

SOX2-dependent expression of dihydroorotate dehydrogenase regulates oral squamous cell carcinoma cell proliferation

Upregulation of sex-determining region Y-box 9 (SOX9) promotes cell proliferation and tumorigenicity in esophageal squamous cell carcinoma

Increased expression of lncRNA CASC9 promotes tumor progression by suppressing autophagy-mediated cell apoptosis via the AKT/mTOR pathway in oral squamous cell carcinoma

LncRNA HOXA-AS2 promotes tumor progression via suppressing miR- 567 expression in Oral Squamous Cell Carcinoma Running title: LncRNA HOXA-AS2 promotes tumor progression in OSCC

miR-30e-5p-mediated FOXD1 promotes cell proliferation by blocking cellular senescence and apoptosis through p21/CDK2/Rb signaling in head and neck carcinoma

Long Non-Coding RNA DUXAP8 Acts as an Oncogene in Sinonasal Squamous Cell Carcinoma Through miR-584-5p/FNDC3B Pathway

Abstract 1143: EZH2 Promotes Oral Squamous Cell Carcinoma Initiation and Progression Through Epigenetic Silencing of FHL1